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The Golgi apparatus acts as a platform for
TBK1 activation after viral RNA sensing
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Damien Vitour5, Ivana Munitic6, Aimé Vazquez1,2,3 and Damien Arnoult1,2,3*
Abstract
Background: After viral infection and the stimulation of some pattern-recognition receptors, TANK-binding kinase I
(TBK1) is activated by K63-linked polyubiquitination followed by trans-autophosphorylation. While the activated
TBK1 induces type I interferon production by phosphorylating the transcription factor IRF3, the precise molecular
mechanisms underlying TBK1 activation remain unclear.
Results: We report here the localization of the ubiquitinated and phosphorylated active form of TBK1 to the
Golgi apparatus after the stimulation of RIG-I-like receptors (RLRs) or Toll-like receptor-3 (TLR3), due to TBK1 K63-linked
ubiquitination on lysine residues 30 and 401. The ubiquitin-binding protein optineurin (OPTN) recruits ubiquitinated TBK1
to the Golgi apparatus, leading to the formation of complexes in which TBK1 is activated by trans-autophosphorylation.
Indeed, OPTN deficiency in various cell lines and primary cells impairs TBK1 targeting to the Golgi apparatus and its
activation following RLR or TLR3 stimulation. Interestingly, the Bluetongue virus NS3 protein binds OPTN at the Golgi
apparatus, neutralizing its activity and thereby decreasing TBK1 activation and downstream signaling.
Conclusions: Our results highlight an unexpected role of the Golgi apparatus in innate immunity as a key subcellular
gateway for TBK1 activation after RNA virus infection.
Abbreviations: BMDM, Bone marrow derived macrophages; IFN, Interferon; IRF3, Interferon regulatory factor (IRF)-3;
ISREs, IFN-stimulated response elements; MEF, Murine embryonic fibroblast; NF-κB, Nuclear factor-kappaB; PBS, Phosphate
buffered saline; PRRs, Pattern-recognition receptors; RLRs, RIG-I-like receptors; TLRs, Toll-like receptors; WT, Wildtype
Background
The innate immune response is the first line of defense
against microbial pathogens, including viruses. After
infection, the replication of a virus within host cells gener-
ates molecular signatures known as pathogen-associated
molecular patterns. The antiviral immune response is
dependent on germline-encoded pattern-recognition re-
ceptors (PRRs), which sense the presence of viral nucleic
acids and trigger a series of signaling pathways leading to
the rapid production of pro-inflammatory cytokines and
type I interferons (IFNα/IFNβ) [1, 2]. Once secreted, type
I IFNs stimulate the transcription of IFN-stimulated genes
to prevent the virus from spreading and to activate the
adaptive immune response [3]. The loss of type I IFN
signaling leads to severe immunodeficiency with a high
susceptibility to viral infection [4].
The various classes of PRRs involved in virus detection
include endosomal Toll-like receptors (TLRs), cytosolic
DexD/H-box retinoic acid-inducible gene-I (RIG-I)-like
receptors (RLRs) and cytosolic DNA receptors [1, 2]. All
antiviral PRRs induce type I IFN expression, but the
signaling components involved differ between PRRs.
However, one common feature of all these signaling
pathways is the recruitment of adaptor proteins to form
a scaffold with the cellular ubiquitin ligases TRAFs. For
instance, viral dsRNA in endosomes is detected by
TLR3, whereas viral RNA in the cytosol is detected by
RLRs, leading to the recruitment of TRIF and MAVS
(this protein being anchored in the mitochondrial outer
membrane), respectively. With the assistance of TRAFs
and through polyubiquitination, these two adaptors then
activate two cytosolic protein kinase complexes, one
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consisting of the ‘non-canonical’ inhibitor of nuclear
factor κB kinase (IKK)-related TANK binding kinase 1
(TBK1) or its close homolog IKKε, associated with vari-
ous adaptor proteins, and the other containing IKKα,
IKKβ, and NEMO [1, 5, 6]. The IKK complex activates
NF-κB, promoting the production of pro-inflammatory
cytokines, and NF-κB activation requires the degradation
of cytoplasmic inhibitors. By contrast, the transcription
factors IRF3 and IRF7 are directly activated in the cyto-
plasm through TBK1-mediated phosphorylation, leading
to their dimerization, translocation to the nucleus and
the initiation of type I IFN production [3, 7].
TBK1 is a key regulator of type I IFN production. In-
deed, the loss of TBK1 has a profound impact on type I
IFN induction after viral infection [7–9]. TBK1 is consti-
tutively expressed and TBK1 deficiency is embryo-lethal,
due to the occurrence of high levels of hepatic apoptosis,
a phenotype very similar to that of IKKβ-deficient mice
[10]. TBK1 activity is regulated by phosphorylation of the
serine 172 residue within the classical kinase activation
loop. The mechanisms of TBK1 activation are not clearly
understood. Genetic and pharmacological inhibition
studies have indicated that TBK1 can be activated by IKKβ
but that activation by trans-autophosphorylation is more
likely [11, 12]. Post-translational modifications of some ly-
sine residues of TBK1 through the addition of K63-linked
polyubiquitin chains have been shown to be required for
TBK1 activation and type I IFN production after viral
infections [13, 14]. Moreover, it has been suggested that
TBK1 autoactivation is dependent on the subcellular loca-
tion of TBK1, with various adaptor proteins each directing
TBK1 to discrete signaling complexes for different cellular
responses [12, 15, 16].
We report here the targeting of ubiquitinated TBK1 to
the Golgi apparatus after RLR or TLR3 stimulation,
through interaction with optineurin (OPTN), an ubiquitin-
binding adaptor protein [17]. OPTN senses the K63-linked
polyubiquitin chains on TBK1, triggering the formation of
TBK1-OPTN complexes, in which TBK1 is activated by
trans-autophosphorylation. TBK1 then phosphorylates
IRF3 to promote type I IFN production to establish an
antiviral response. Interestingly, the Bluetongue virus NS3
protein neutralizes OPTN activity at the Golgi apparatus,
thereby decreasing TBK1 activation and downstream sig-
naling. Our observations thus reveal an unexpected new
function of the Golgi apparatus in innate immunity.
Results
The active form of TBK1 localizes to the Golgi apparatus
after RLR or TLR3 activation
We recently reported that ubiquitinated transmitters in-
volved in NF-κB activation accumulate at the surface of
the endoplasmic reticulum [18]. This raised questions as
to whether some endomembranes might also act as sites
of accumulation for ubiquitinated transmitters involved
in activation of the transcription factor IRF3. To explore
this hypothesis, murine embryonic fibroblasts (MEFs)
were infected with Sendai virus to stimulate the RLR sig-
naling pathway. Differential centrifugation was then used
to separate the different membrane fractions, as indi-
cated in Additional file 1A. With this approach, while a
significant proportion of TBK1 was found in the cyto-
solic fraction (S25), unexpectedly, the ubiquitinated and
phosphorylated active form of TBK1 (p-TBK1S172) was
detected mostly in the Golgi-enriched fraction (P25), and
this TBK1 activation was associated with the phosphoryl-
ation of its substrate IRF3 (Fig. 1a). Immunofluorescence
confirmed that IRF3 was activated, as it was translocated
to the nucleus after infection (Fig. 1b). TBK1 staining
was not affected by RLR activation (Fig. 1c), whereas
p-TBK1S172 was detected at the Golgi apparatus (Fig. 1d
and Additional file 1B), but not at mitochondria (Fig. 1e).
Similarly, the infection of HeLa cells with Sendai virus led
to a detection of the active form of TBK1 at the Golgi
apparatus (Additional file 2A–E). TBK1–/– MEFs con-
firmed the specificity of the used antibody raised against
p-TBK1S172 (Fig. 1f) and, at later time points post-infection,
we observed that the active form of TBK1 accumulates very
close to the Golgi apparatus, at the centrosome (Additional
file 1D and E). Importantly, RLR activation promoted the
K63-linked polyubiquitination of TBK1, as previously
reported (Additional file 2F) [13].
For further confirmation of the presence of the active
form of TBK1 at the Golgi apparatus after RLR stimulation,
cell fractions from control or infected cells were separated
on Optiprep gradients to yield fractions enriched in Golgi
apparatus, endoplasmic reticulum, or mitochondria. Un-
modified TBK1 was detected in multiple fractions, whereas
the ubiquitinated and phosphorylated protein was essen-
tially limited to fractions enriched in the Golgi protein
syntaxin-6 (Fig. 1g). p-TBK1S172 was also detected, using
discontinuous density gradients, in Golgi membranes iso-
lated from Sendai virus-infected cells (Additional file 1C).
Finally, to demonstrate that the active form of TBK1
was mostly located at the Golgi apparatus but not at the
mitochondria after RLR stimulation, increased concen-
trations of mitochondria- (P5) or Golgi-enriched (P25)
fractions of control or Sendai virus-infected cells were
incubated with recombinant IRF3 in the presence of
ATP. The mitochondria-enriched fraction of infected
cells triggered the phosphorylation of recombinant IRF3,
but this phosphorylation was significantly weaker than
that observed with the Golgi-enriched fraction, in which
most of the p-TBK1S172 was found (Fig. 1h). Our results
are consistent with the reports that TBK1 does not sedi-
ment in the high molecular weight fractions together
with the prion-like aggregates of MAVS at the mito-
chondria in response to Sendai virus infection [19, 20].
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Within the endosomes, viral dsRNA is detected by
TLR3, and the activation of this PRR leads to TBK1 acti-
vation after recruitment of the TRIF adaptor [2]. We
therefore investigated whether active TBK1 was also
found at the Golgi apparatus after TLR3 stimulation.
HEK293 cells stably expressing HA-tagged TLR3 were
stimulated with poly(I:C), an analog of viral dsRNA, and
then differential centrifugation was performed to
separate the various membrane fractions, as in Additional
file 1A. As observed after RLR stimulation, the ubiquiti-
nated and phosphorylated active form of TBK1 was mostly
present in the Golgi-enriched fraction (Fig. 2a). Immuno-
fluorescence studies confirmed the presence of active TBK1
at the Golgi apparatus but not at the endosomes after
TLR3 stimulation (Fig. 2b, c). Optiprep gradients further
demonstrated that p-TBK1S172 was concentrated in the
Golgi-enriched fraction (Fig. 2d) and that this fraction
could phosphorylate recombinant IRF3 in vitro (Fig. 2e).
Fig. 1 Localization of the active form of TBK1 at the Golgi apparatus after RLR stimulation. a MEFs were either left unstimulated or infected with Sendai
virus (SeV) for 6 or 8 h. MEFs were then fractionated as described in Additional file 1A, and samples were analyzed by immunoblotting with antibodies
against the indicated proteins. EEA1, kinectin, LAMP2, GAPDH, syntaxin-6, and VDAC served as loading and purity controls for endosomes, the endoplasmic
reticulum, lysosomes, the cytosol, the Golgi apparatus, and mitochondria, respectively. (Ub)n, polyubiquitin. * Indicates non-specific bands. b–e MEFs were
either left unstimulated (control) or infected with SeV for 6 h (+ SeV). The indicated proteins were then analyzed by immunofluorescence. The Golgi
apparatus was stained with an antibody raised against GM130, whereas the mitochondria were identified by labeling with an antibody against
cytochrome c. Scale bars, 10 μm. On the right, enlargement of the framed zone in the overlay. f WT or TBK1–/– MEFs were either left unstimulated
(control) or infected with SeV for 6 h (+ SeV). p-TBK1S172 staining was then analyzed by immunofluorescence. The Golgi apparatus was stained with
an antibody raised against GM130. Scale bars, 10 μm. g Crude heavy membrane fractions from uninfected or SeV-infected MEFs were fractionated
on OptiPrep density gradients (fractions range from 1 at the top to 4 at the bottom) and analyzed by immunoblotting with antibodies against the
indicated proteins. (Ub)n, polyubiquitin. h Increased concentrations of mitochondria (P5) or Golgi (P25)-enriched fractions of unstimulated (Unst) or
SeV-infected HEK293T cells were incubated with recombinant GST-IRF3 in the presence of ATP. The degree of IRF3 phosphorylation was determined
by immunoblotting
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Thus, regardless of the viral pathogen-associated molecular
pattern sensing location, i.e. cytoplasmic RLR or endosomal
TLR, the active form of TBK1 is localized at the Golgi
apparatus.
Potent RLR activation triggers TBK1 targeting and
aggregation at the Golgi apparatus
After RLR stimulation, TBK1 activation is initiated at the
mitochondria through the essential adaptor MAVS [2, 6].
However, active TBK1 was detected at the Golgi apparatus
following Sendai virus infection suggesting the targeting
of TBK1 to this organelle. This redistribution of TBK1
was further studied by stimulating RLRs in MEFs by trans-
fection with poly(I:C), which is sensed in the cytosol by
RIG-I or melanoma differentiation-associated gene-5, in a
size-dependent manner [21]. Interestingly, transfection
with low- or high-molecular weight poly(I:C) for 2 hours
triggered a TBK1 aggregation at the Golgi apparatus
(Fig. 3a). TBK1 staining was lost in TBK1–/– MEFs
(Fig. 3b) confirming the specificity of the anti-TBK1 anti-
body and this TBK1 aggregation was also detected with
another antibody raised against the kinase (Additional
file 3A). TBK1 aggregation was associated with the nuclear
translocation of IRF3 (Fig. 3c) and these aggregates do not
co-localize with the autophagosomes (data not shown).
Interestingly, 4 hours after poly(I:C) transfection, TBK1 ac-
cumulated at the centrosome, which is surrounded by the
Golgi apparatus next to the nucleus (Additional file 3B, C).
Fig. 2 The active form of TBK1 localizes at the Golgi apparatus after TLR3 stimulation. a HEK293T cells stably expressing HA-TLR3 were either left
untreated or stimulated with poly(I:C) (10 μg/mL) for 30 or 60 minutes. Cells were then fractionated as described in Additional file 1A, and samples
were analyzed by immunoblotting with antibodies against the indicated proteins. EEA1, kinectin, LAMP2, GAPDH, syntaxin-6, and VDAC served as
loading and purity controls for endosomes, the endoplasmic reticulum, lysosomes, the cytosol, the Golgi apparatus, and mitochondria, respectively.
(Ub)n, polyubiquitin. * Indicates non-specific bands. b, c HEK293T cells stably expressing HA-TLR3 were either left untreated (control) or stimulated
with poly(I:C) (10 μg/mL) for 1 h (+ Poly(I:C)). The indicated proteins were then analyzed by immunofluorescence. The Golgi apparatus was stained with
an antibody against GM130, and an antibody against EEA1 was used to stain endosomes. Scale bars, 10 μm. In b, on the right, enlargement of the
framed zone in the overlay. d Crude heavy membrane fractions from unstimulated or poly(I:C)-treated HEK293T cells stably expressing HA-TLR3 were
fractionated on OptiPrep density gradients (fractions range from 1 at the top to 4 at the bottom) and analyzed by immunoblotting with
antibodies against the indicated proteins. (Ub)n, polyubiquitin. * Indicates non-specific bands. e Increased concentrations of mitochondria- (P5) or
Golgi (P25)-enriched fractions of unstimulated (Unst) or poly(I:C)-treated HEK293T cells stably expressing HA-TLR3 were incubated with recombinant
GST-IRF3 in the presence of ATP. The degree of IRF3 phosphorylation was determined by immunoblotting
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TBK1 aggregation was completely inhibited by transfection
with poly(I:C) in MAVS–/– MEFs but not in STING–/–
MEFs (Fig. 3d), STING being a crucial adaptor involved in
cytosolic DNA sensing pathways anchored in the endo-
plasmic reticulum [22].
After the transfection of cells with poly(I:C), p-TBK1S172
was first detected at the Golgi apparatus (Fig. 3e) next at
the centrosome (Additional file 3D and E) as observed
during Sendai virus infection. Finally, as expected, the
TBK1 aggregates consisted of the phosphorylated and
ubiquitinated active form of the kinase (Fig. 3f, g and
Additional file 4).
Ubiquitination targets TBK1 to the Golgi apparatus for
activation
The K63-linked polyubiquitination of TBK1 on lysines 30
and 401 is required for the activation of this kinase [14].
Thus, whereas the overexpression of wildtype (WT) TBK1
led to activation of the kinase through trans-autophospho-
rylation, TBK1 activation was impaired after overexpres-
sion of the TBK1K30R/K401R double mutant (Fig. 4a). The
expression of a kinase-inactive mutant (K38M mutant) as
a positive control did not trigger TBK1 activation (Fig. 4a).
Consistent with these findings, significantly weaker stimu-
lation of the IFNβ promoter was observed in luciferase
Fig. 3 TBK1 forms aggregates at Golgi apparatus following potent RLR activation. a MEFs were either left untreated (MOCK) or transfected with
HMW poly(I:C) (5 μg/mL) for 2 h (trPoly(I:C)). TBK1 staining was then analyzed by immunofluorescence. The Golgi apparatus was identified by
labeling with an antibody raised against GM130. Scale bars, 10 μm. On the right, enlargement of the framed zone in the overlay. b WT or TBK1–/–
MEFs were stained with an antibody raised against TBK1, then analyzed by immunofluorescence analysis. c MEFs were either left untreated
(MOCK) or transfected with HMW poly(I:C) (5 μg/mL) for 2 h (trPoly(I:C)). The indicated proteins were analyzed by immunofluorescence analysis
with specific antibodies. Scale bars, 10 μm. d WT, MAVS–/–, or STING–/– MEFs were either left untreated (MOCK) or transfected with HMW poly(I:C)
(5 μg/mL) for 4 h (trPoly(I:C)). TBK1 aggregation was assessed by immunofluorescence staining and aggregate counting. The data shown are
means ± SD from three independent experiments (300 cells were counted per condition). ***P < 0.001 versus WT MEFs (Student’s t test). ns, not
significant. e–g MEFs were either left untreated (MOCK) or transfected with HMW poly(I:C) (5 μg/mL) for 2 or 4 h (trPoly(I:C)). The indicated
proteins were analyzed by immunofluorescence analysis with specific antibodies. The Golgi apparatus was stained with an antibody against
GM130. Scale bars, 10 μm
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assays after the overexpression of TBK1K30R/K401R than
with WT TBK1, and the promoter was not activated with
TBK1K38M (Fig. 4b). Interestingly, NF-κB activation was
not weaker with the polyubiquitination mutant than for
the WT, whereas this activation was prevented with the
kinase-inactive mutant (Fig. 4b).
Following our detection of ubiquitinated active TBK1
at the Golgi apparatus, we hypothesized that the target-
ing of TBK1 to the Golgi apparatus might be impaired
in the absence of ubiquitination. We tested this hypoth-
esis by reconstituting TBK1–/– MEFs with WT or mu-
tant TBK1 constructs (Fig. 4c), and then investigating
TBK1 aggregation after transfection with poly(I:C). Stimu-
lation triggered TBK1 aggregation in cells reconstituted
with WT TBK1, but this aggregation was significantly
impaired with the K30R/K401R polyubiquitination mutant
(Fig. 4d). In parallel, the expression of the IRF3 target gene
IFNB1 was analyzed. Transfection with poly(I:C) increased
IFNB1 mRNA levels in cells reconstituted with WT
TBK1, but this response was abolished with the poly-
ubiquitination mutant (Fig. 4e), as previously described
[14]. We also reconstituted TBK1–/– MEFs with the
kinase-inactive mutant. TBK1 aggregation was unaffected
(Fig. 4d), but the transcriptional response was completely
inhibited (Fig. 4e). Thus, TBK1 polyubiquitination on
conserved lysines 30 and 401 targets TBK1 to the Golgi
apparatus in a process linked to the phosphorylation of
the Ser172 residue in the kinase activation loop after
dimerization [14]. These observations are consistent with
the hypothesis developed from findings for structural
Fig. 4 Ubiquitination promotes TBK1 targeting to the Golgi apparatus for activation. a HEK293T cells were transfected with an empty vector (Ev)
or with plasmids encoding myc-tagged WT TBK1 (WT), TBK1K38M (K38M), or TBK1K30R/K401R (K30R/K401R). After 16 h, TBK1 activation and exogenous
TBK1 expression were assessed by immunoblotting with anti-p-TBK1S172 and anti-myc antibodies, respectively. GAPDH was used as a loading
control. b HEK293T cells were transfected with either an IFNβ promoter reporter or an NF-κB reporter, together with the Renilla luciferase gene as
an internal control. In parallel, the cells were also transfected with an Ev or with plasmids encoding myc-tagged WT TBK1 (WT), TBK1K38M (K38M),
or TBK1K30R/K401R (K30R/K401R). Luciferase assays were performed 24 h after transfection and the results were normalized against Renilla luciferase
activity. The data shown are means ± SD from three independent experiments (analysis of variance and comparison with WT TBK1 in Student’s t
test). RLU, relative luminescence units. c Immunoblotting analysis of TBK1–/– MEFs reconstituted with WT TBK1, TBK1K38M (K38M), or TBK1K30R/K401R
(K30R/K401R). As controls, TBK1+/+ and TBK1–/– MEFs are shown. d TBK1–/– MEFs reconstituted with WT TBK1 or mutants were either left untreated
(MOCK) or transfected with HMW poly(I:C) (5 μg/mL) for 4 h (trPoly(I:C)). TBK1 aggregation was then assessed by immunofluorescence staining
and counting of the aggregates. The data shown are means ± SD from three independent experiments (300 cells were counted per condition).
**0.001 < P < 0.01 versus MEFs reconstituted with WT TBK1 (Student’s t test). e The reconstituted MEFs described in (c) and the initial TBK1–/– MEFs were
transfected with HMW poly(I:C) (5 μg/mL) for 0, 2, and 4 h (trPoly(I:C)). IFNB1 mRNA levels were then assessed by RT-qPCR with normalization against
GAPDH. The data shown are means ± SD from three independent experiments (analysis of variance and comparison with WT TBK1-reconstituted MEFs
in Student’s t test). AU, arbitrary unit
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studies concerning the key role of cellular localization in
the activation of TBK1 [12].
OPTN is required for optimal TBK1 activation after RLR or
TLR3 stimulation
A structural study has also suggested that the binding of
polyubiquitin chains triggers the higher-order oligo-
merization of TBK1-adaptor complexes, resulting in the
trans-autophosphorylation and activation of the kinase
[11]. As observed after RLR or TLR3 stimulation, the ubi-
quitinated and phosphorylated active form of TBK1 was
detected at the Golgi apparatus. This suggested that an
adaptor of ubiquitinated TBK1 was present at this organ-
elle to promote the activation of TBK1. We identified
optineurin (OPTN) as a likely candidate for this role.
Indeed, this protein has an ubiquitin-binding domain
(UBD) and a C-terminal ubiquitin-binding zinc finger
(ZF), and is located at the Golgi apparatus [17, 23]. It has
also been reported to be required for optimal TBK1
activation [24–28]. Immunofluorescence studies with
three different antibodies against OPTN confirmed that a
part of this protein is located at the Golgi apparatus
(Additional file 5A), as previously reported [17, 23].
Moreover, OPTN was also detected in isolated Golgi
membranes (Additional file 1C). Following infection with
Sendai virus, leading to RLR activation, an increase in the
association of TBK1 with OPTN was detected (Fig. 5a)
and p-TBK1S172 was found in complex with OPTN in the
Golgi-enriched fraction (Additional file 5B).
We then carried out assays on HEK293T cells with a
luciferase reporter under the control of the IFNβ pro-
moter or driven by three copies of an NF-κB enhancer.
We found that stimulation of the IFNβ promoter after
RLR activation is impaired in cells in which OPTN ex-
pression was knocked down with two different siRNAs,
whereas NF-κB activation was unaffected (Fig. 5b).
These results were confirmed with three other OPTN
siRNAs (Additional file 6A). As a control, NEMO ex-
pression was knocked down, as this protein activates
both the NF-κB and IRF signaling pathways downstream
from MAVS [29] and its loss inhibited both pathways
(Fig. 5b). Biochemical studies in both HEK293T and
HeLa cells confirmed that transfection with siRNAs
against OPTN impairs TBK1 activation and subsequent
signaling after RLR stimulation, but has no effect on the
NF-κB and ERK pathways (Additional files 6B and C).
The infection of OPTN siRNA-transfected cells with an-
other RNA virus, such as the vesicular stomatitis virus,
to activate the RLRs, yielded similar results (Additional
files 6D and E). Similarly, OPTN silencing in MEFs
impaired TBK1 activation and IRF3 phosphorylation
without altering NF-κB or ERK signaling after Sendai
virus infection (Fig. 5c). Importantly, TBK1 aggregation
at the Golgi apparatus after poly(I:C) transfection was
prevented by the silencing of OPTN (Fig. 5d). This sug-
gests that OPTN senses ubiquitinated TBK1 at the Golgi
apparatus and promotes its activation, because the ubi-
quitination of TBK1 is required for its targeting to this
organelle (Fig. 4).
OPTN expression was also abolished with CRISPR/
Cas9 technology in HeLa cells and the cells were then
infected with Sendai virus. As expected, the IRF3 signal-
ing pathway was decreased in OPTN knockout cells,
whereas the NF-κB and ERK pathways were not (Fig. 5e).
Consequently, smaller amounts of IFNβ were produced
and secreted, but no effect was observed on the NF-κB
target IL-6 (Fig. 5f–i). Finally, the lack of OPTN did not
affect the K63-linked polyubiquitination of TBK1 after
RLR stimulation (Additional file 7).
As ubiquitinated active TBK1 was uncovered at the
Golgi apparatus after TLR3 stimulation (Fig. 2), we also
explored the possible involvement of OPTN in TBK1 ac-
tivation downstream from this PRR. Hence, an increased
association between OPTN and TBK1 was detected after
TLR3 stimulation (Fig. 5j). We then silenced OPTN, and
both luciferase assays and immunoblots showed that
knocking down the levels of this protein selectively
inhibited the IRF3 signaling pathway (Fig. 5k, l and
Additional file 6F).
OPTN insufficiency impairs TBK1 activation after RLR or
TLR3 stimulation in primary cells
For further confirmation of the requirement of OPTN
for TBK1 activation, we used primary cells from mice in
which both the UBD and ZF domains of OPTN had
been deleted (OPTN470T) [27]. The truncated protein
was produced in smaller amounts than the WT protein,
allowing to investigate the effects of both defective Ub
binding and OPTN insufficiency [27]. First, primary
MEFs were infected with Sendai virus. OPTN470T MEFs
displayed weaker TBK1 activation than WT MEFs, to-
gether with lower levels of phosphorylation of IRF3, with
no effect on ERK or NF-κB signaling (Fig. 6a). Con-
firming these observations, levels of IFNB1 mRNA and
of IFNβ release were lower in the OPTN470T MEFs,
whereas the production and secretion of IL-6 were un-
affected (Fig. 6b–e). Furthermore, consistent with OPTN
being required for recruiting ubiquitinated TBK1 to the
Golgi apparatus, significantly less TBK1 aggregation was
observed with the mutated OPTN (Fig. 6f ). Finally, the
comparison of WT and OPTN470T bone marrow derived
macrophages (BMDM) stimulated with poly(I:C) also
confirmed that OPTN positively regulates TBK1 activa-
tion and downstream signaling after TLR3 stimulation
without influencing NF-κB or ERK signaling (Fig. 6g–k).
Together, our results suggest that OPTN recruits, at
the Golgi apparatus, ubiquitinated TBK1 downstream
from both RLRs and TLR3 in order to promote TBK1
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Fig. 5 OPTN silencing impairs TBK1 activation after RLR or TLR3 activation. a HEK293T cells were either left unstimulated or infected with Sendai virus
(SeV) for 6 and 8 h. Cell lysates (Lys.) were subjected to immunoprecipitation (IP) with an antibody against OPTN. Samples were then analyzed by
immunoblotting with antibodies against the indicated proteins. b HEK293T cells were transfected with a control non-specific siRNA (NS) or with two
individual OPTN-specific siRNAs (OPTN A and OPTN B) or a NEMO-specific siRNA. The cells were then transfected, 48 h later, with an IFNβ promoter
reporter or with a NF-κB reporter and the Renilla luciferase gene as an internal control. Then, 24 h after transfection, cells were either left unstimulated
(Unstim) or infected with Sendai virus (+ SeV) for 7 h. Luciferase assays were performed and the results were normalized against Renilla luciferase activity.
The data shown are means ± SD from three independent experiments. ****P< 0.0001 versus the NS siRNA-transfected cells (Student’s t test). RLU, relative
luminescence units. ns, not significant. c MEFs were transfected with a control non-specific siRNA (NS) or with two individual OPTN-specific siRNAs (OPTN
1 and OPTN 2) or a NEMO-specific siRNA. Then, 72 h later, cells were either left unstimulated or infected with SeV for 6 or 8 h. Cell lysates were analyzed
by immunoblotting with antibodies against the indicated proteins. * Indicates non-specific bands. d MEFs were transfected with a control non-specific
siRNA (NS) or with two individual OPTN-specific siRNAs (OPTN 1 and OPTN 2). Then, 72 h later, cells were either left untreated (MOCK) or transfected with
high molecular weight poly(I:C) (5 μg/mL) for 4 h (trPoly(I:C)). TBK1 aggregation was assessed by immunofluorescence staining and counting of the
aggregates. The data shown are means ± SD from three independent experiments (300 cells were counted per condition). **0.001 < P< 0.01 versus the
NS siRNA-transfected cells (Student’s t test). e WT or OPTN KO HeLa cells were infected with SeV for the indicated times. Cell lysates were then analyzed
by immunoblotting with antibodies against the indicated proteins. * Indicates a non-specific band. f–i WT or OPTN KO HeLa cells were infected with SeV
for the indicated times. IFNB1 and IL-6 mRNA levels were then assessed by RT-qPCR with normalization against GAPDH (f, g), or the production of IFNβ
and IL-6 was analyzed by ELISA in the cell supernatant (h, i). The data shown are means ± SD from three independent experiments (analysis of variance
and comparison with WT HeLa cells in Student’s t test). ns, not significant; AU, arbitrary unit. j HEK293T cells stably expressing TLR3 (HEK293-TLR3) were
either left unstimulated or stimulated with poly(I:C) (10 μg/mL) for 30 or 60 minutes. Cell lysates (Lys.) were subjected to immunoprecipitation (IP) with an
antibody against OPTN. Samples were then analyzed by immunoblotting with antibodies against the indicated proteins. ° Corresponds to TBK1 detection
from a previous immunoblot. k HEK293-TLR3 cells were transfected with a control non-specific siRNA (NS) or with two individual OPTN-specific siRNAs
(OPTN A and OPTN B) or a NEMO-specific siRNA. The cells were then transfected, 48 h later, with an IFNβ promoter reporter or with a NF-κB reporter and
the Renilla luciferase gene as an internal control. Then, 24 h after transfection, cells were either left unstimulated (Unstim) or stimulated with poly(I:C)
(10 μg/mL) for 7 h. Luciferase assays were performed and the results were normalized against Renilla luciferase activity. The data shown are means ± SD
from three independent experiments (analysis of variance and comparison with the NS siRNA-transfected cells in Student’s t test). ns, not significant.
l HEK293-TLR3 cells were transfected as in (k). Then, 72 h later, cells were either left unstimulated or stimulated with poly(I:C) (10 μg/mL) for
30 or 60 minutes. Cell lysates were then analyzed by immunoblotting with antibodies against the indicated proteins
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activation and a signaling pathway resulting in the pro-
duction of type I IFNs.
The NS3 protein of the Bluetongue virus targets OPTN to
dampen IRF3 signaling
Viruses have developed a battery of different strategies for
overcoming the very sophisticated defense mechanisms of
infected hosts. During the course of pathogen–host co-
evolution, viruses have acquired an ability to inhibit the
innate immune response by targeting host proteins [30].
Our results suggested that OPTN is important for TBK1
activation after RLR or TLR3 activation. We therefore hy-
pothesized that there might be viral proteins capable of
neutralizing the activity of OPTN, thereby preventing it
from performing its function in innate immunity.
Non-structural protein 3 (NS3) of the Bluetongue
virus, a dsRNA virus, has been localized to the Golgi
apparatus and shown to specifically modulate the type I
IFN signaling pathway [31, 32]. We confirmed that NS3
expression led to the detection of this protein at the
Golgi apparatus (Fig. 7a) and that, in luciferase assays,
NS3 affected the stimulation of the IFNβ promoter but
not NF-κB activation after RLR stimulation (Fig. 7b).
Accordingly, NS3 expression decreased the phosphoryl-
ation of both TBK1 and IRF3 (Fig. 7c). As NS3 was
targeted to the Golgi apparatus and decreased TBK1 ac-
tivation, we then hypothesized that NS3 binds to OPTN
to prevent it from activating TBK1. Immunoprecipita-
tion experiments demonstrated that NS3 binds to OPTN
(Fig. 7d) and, in cells expressing NS3, the association be-
tween OPTN and TBK1 was impaired after viral infec-
tion (Fig. 7e), accounting for the lower levels of TBK1
activation observed (Fig. 7c). Finally, TBK1 aggregation
was inhibited in the presence of the viral protein,
Fig. 6 Impaired TBK1 activation after RLR or TLR3 stimulation in OPTN-deficient primary cells. a Primary MEFs isolated from WT or OPTN470T mice
were infected with Sendai virus (SeV) for the indicated times. Cell lysates were then analyzed by immunoblotting with antibodies against the
indicated proteins. * Indicates a non-specific band. b, c Primary MEFs isolated from WT or OPTN470T mice were infected with SeV for the indicated
times. IFNB1 and IL-6 mRNA levels were assessed by RT-qPCR with normalization against GAPDH. The data shown are means ± SD from three
independent experiments (analysis of variance and comparison with WT MEFs in Student’s t test). ns, not significant; AU, arbitrary unit. d, e Primary
MEFs isolated from WT or OPTN470T mice were either left unstimulated or infected with SeV for 6 or 8 h. The production of IFNβ and IL-6 was then
analyzed by ELISA in the cell supernatant. The data shown are means ± SD from three independent experiments (analysis of variance and comparison with
WT MEFs in Student’s t test). ns, not significant. f Primary MEFs isolated from WT or OPTN470T mice were either left untreated (MOCK) or transfected with
HMW poly(I:C) (5 μg/mL) for 4 h (trPoly(I:C)). TBK1 aggregation was assessed by immunofluorescence staining and aggregate counting. The data shown
are means ± SD from three independent experiments (300 cells were counted per condition). **0.001 < P< 0.01 versus WT MEFs (Student’s t test). g BMDM
isolated from WT or OPTN470T mice were stimulated with poly(I:C) (1 μg/mL) for the indicated times. Cell lysates were then analyzed by immunoblotting
with antibodies against the indicated proteins. h–k BMDM isolated from WT or OPTN470T mice were stimulated with poly(I:C) (1 μg/mL) for the indicated
times. IFNB1 and IL-6 mRNA levels were then assessed by RT-qPCR with normalization against GAPDH (h, i), or the production of IFNβ and IL-6 was
analyzed by ELISA in the cell supernatant (j, k). The data shown are means ± SD from three independent experiments (analysis of variance and
comparison with WT BMDM in Student’s t test). ns, not significant; AU, arbitrary unit
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confirming its ability to neutralize the activity of OPTN
(Fig. 7f ). Thus, the fact that OPTN is targeted by a viral
protein to dampen type I IFN signaling reinforces our
findings that OPTN is an important effector in TBK1
activation.
Discussion
Viral RNAs in endosomes are detected by TLR3, whereas
those in the cytosol are detected by RLRs [2]. The stimula-
tion of either of these PRRs leads to TBK1 activation and
this kinase plays a crucial role in innate antiviral immunity
through the phosphorylation of IRF3, which is required
for the production of type I IFNs [7–9]. However, the pre-
cise molecular mechanisms underlying TBK1 activation
are unclear. Surprisingly, after the stimulation of cells with
IL-1β or TNFα, after mitophagy induction or in cancer
dependent on KRAS signaling, TBK1 is phosphorylated
whereas IRF3 is not [25, 26, 33, 34]. It has been therefore
suggested that TBK1 autoactivation and substrate specifi-
city are both dependent on the subcellular distribution of
TBK1, with various adaptor proteins each directing TBK1
to discrete signaling complexes for different cellular re-
sponses [12, 15, 16]. Consistent with this hypothesis, we
observed that the active form of TBK1 is present at the
Golgi apparatus after the stimulation of RLRs or TLR3,
and that its substrate, IRF3, is phosphorylated. In the case
of mitophagy, p-TBK1S172 is recruited to depolarized
mitochondria without IRF3 phosphorylation [25]. No sig-
nificant accumulation of active TBK1 was detected at the
Golgi apparatus after the treatment of cells with IL-1β or
Fig. 7 OPTN is targeted by the NS3 protein of the Bluetongue virus to dampen IRF3 signaling. a HeLa cells were transfected with a plasmid
encoding NS3-GFP; 16 h later, the NS3-GFP localization was assessed by immunofluorescence analysis. The Golgi apparatus was stained with an
antibody against GM130. Scale bars, 10 μm. b HEK293T cells were transfected with either an IFNβ promoter reporter or with a NF-κB reporter,
together with the Renilla luciferase gene as an internal control. In parallel, the cells were also transfected with a plasmid encoding GFP or NS3-GFP.
Then, 16 h after transfection, cells were either left unstimulated (Unstim) or infected with Sendai virus (+ SeV) for 7 h. Luciferase assays were then
performed and the results were normalized against Renilla luciferase activity. The data shown are means ± SD from three independent experiments
(analysis of variance and comparison with GFP-transfected cells in Student’s t test). RLU, relative luminescence units. c HEK293T cells were transfected
with a plasmid encoding GFP or NS3-GFP. Then, 16 h after transfection, cells were infected with SeV for the indicated times. Cell lysates were analyzed
by immunoblotting with antibodies against the indicated proteins. d HEK293T cells were transfected with a plasmid encoding OPTN and a plasmid
encoding GFP or NS3-GFP. Then, 16 h after transfection, cell lysates (Lys.) were subjected to immunoprecipitation (IP) with an antibody against GFP.
Samples were analyzed by immunoblotting with antibodies against the indicated proteins. e HEK293T cells were transfected with a plasmid encoding
GFP or NS3-GFP. Then, 16 h after transfection, cells were either left unstimulated or infected with Sendai virus for 7 h. Cell lysates (Lys.) were then
subjected to immunoprecipitation (IP) with an antibody against OPTN. Samples were analyzed by immunoblotting with antibodies against the indicated
proteins. f MEFs were transfected with a plasmid encoding GFP or NS3-GFP. Then, 16 h after transfection, cells were either left untreated (MOCK) or
transfected with HMW poly(I:C) (5 μg/mL) for 4 h (trPoly(I:C)). TBK1 aggregation was assessed by immunofluorescence staining and aggregate counting
in GFP-positive cells. The data shown are means ± SD from three independent experiments (300 cells were counted per condition). ***P< 0.001 versus
cells transfected with GFP alone (Student’s t test)
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TNFα (data not shown), further suggesting that the pres-
ence of p-TBK1S172 at the Golgi apparatus is a prerequisite
for the phosphorylation of IRF3 by this kinase.
A recent study has elegantly demonstrated that the
adaptor proteins MAVS and TRIF (but also STING) har-
bor conserved domains that are phosphorylated by IKKβ
and/or TBK1 in response to stimulation [34]. Phosphor-
ylated adaptor then binds to a positively charged surface
of IRF3, thereby recruiting this transcription factor for
its phosphorylation and activation by TBK1 [34]. While
localized at the Golgi apparatus, active TBK1 does have
the possibility to phosphorylate either MAVS or TRIF to
promote IRF3 recruitment and ensuing activation of this
transcription factor. Indeed, mitochondria (where MAVS
anchors) and endosomes (where TRIF is recruited after
TLR3 stimulation) through their dynamics or through
their trafficking, respectively, are always in close proximity
to the Golgi apparatus therefore permitting TBK1 to
phosphorylate the adaptor proteins, a process required for
IRF3 activation [34]. IFR3 phosphorylation around the
Golgi apparatus, an organelle bordering the nucleus where
this transcription factor migrates after activation, therefore
reduces the possibility of IRF3 to meet phosphatases or E3
ubiquitin ligases that negatively regulate signaling.
A K63-linked polyubiquitination on lysines 30 and 401
is required in the process of TBK1 activation to permit
this kinase to phosphorylate IRF3 [13, 14]. Our demon-
stration that this ubiquitination leads to the targeting of
TBK1 to the Golgi apparatus for activation suggests that
the ubiquitination sites of TBK1 (this kinase possesses
more than 50 lysine residues conserved between humans
and mice) might affect the subcellular distribution of this
protein and the resulting signaling. It would be interesting
to determine whether TBK1 is ubiquitinated after mito-
chondrial depolarization and, if so, on which lysine resi-
dues, for its targeting and activation at the mitochondria
for mitophagy, as recently described [25, 26].
One key finding of this study is that ubiquitinated TBK1
is sensed by OPTN at the Golgi apparatus, promoting its
trans-autophosphorylation after RLR or TLR3 stimulation.
The binding of the K63-linked polyubiquitin chains on
TBK1 to the UBD of OPTN probably triggers the
oligomerization of TBK1-OPTN complexes, resulting in
trans-autophosphorylation and TBK1 activation, as previ-
ously suggested [11] (Additional file 8). OPTN therefore
appears to be a positive regulator of TBK1 activation
through its polyubiquitin binding activity, as previously
described [24, 27]. However, two other studies have sug-
gested that OPTN negatively regulates TBK1 activation
after RNA virus infection [35, 36]. We currently have no
explanation for this discrepancy. Indeed, OPTN silencing
with multiple siRNAs in HEK293T, HeLa cells, or MEFs,
and OPTN knockout with CRISPR/Cas9 technology in
HeLa cells, MEFs, and BMDMs from OPTN-deficient
mice clearly demonstrated an important role of this
adaptor in TBK1 activation after RLR and TLR3 stimula-
tion. Consistent with the involvement of OPTN in TBK1
activation, it has recently been reported that OPTN, again
through its polyubiquitin binding activity, is required for
TBK1 activation in response to mitochondrial depolar-
ization [25, 26]. Moreover, during the preparation of this
manuscript, a study reported that osteoclast precursors
from OPTN mutant mice produced abnormally low levels
of IFNβ in response to RANKL [37]. Additionally, another
study reported that BMDM from OPTN–/– mice displayed
impaired IRF signaling and low levels of type I IFN pro-
duction in response to poly(I:C) [28]. Finally, further
evidence for the involvement of OPTN in TBK1 activation
is provided by our finding that the NS3 protein of the
Bluetongue virus targets OPTN at the Golgi apparatus,
decreasing TBK1 activation and the resulting IRF3 signal-
ing. Thus, this RNA virus prevents OPTN from activating
TBK1 as part of a strategy to modulate the innate immune
response to facilitate its replication after infection.
Consistent with this finding, other viruses have evolved
strategies for targeting the adaptor proteins involved in
TBK1 activation. The Vaccinia virus protein C6 binds
TBK1 adaptor proteins (TANK, NAP1, and SINTBAD),
thereby inhibiting the activation of IRF3 and IRF7 [38],
and the Gn protein of hantaviruses disrupts the formation
of TBK1 complexes, thereby blocking downstream re-
sponses [39].
In addition to acting as a sensor for ubiquitinated TBK1
at the Golgi apparatus for the kinase activation, OPTN
has also been reported to be a substrate of TBK1. Indeed,
phosphorylation of the Ser177 residue of OPTN by TBK1
increases the association of OPTN with LC3 during xeno-
phagy for the clearance of cytosolic Salmonella and the re-
striction of intracellular bacterial proliferation [40]. Two
independent studies have reported that RNA polymerase
III detects DNA of viral or bacterial origin in the cyto-
plasm and induces type I IFNs via the RLR pathway [41,
42]. It therefore seems possible that stimulation of the
RLR pathway after bacterial infection promotes TBK1 ac-
tivation by OPTN at the Golgi apparatus and that, on the
one hand, p-TBK1S172 triggers the production of type I
IFNs and, on the other, the active kinase phosphorylates
OPTN to induce the xenophagy of the invading bacteria.
OPTN is associated to Golgi apparatus through an
interaction with Rab8 and the interacting domain of
OPTN is localized between amino acids 141–209, com-
prising therefore Ser177 [43]. After TBK1 activation, the
phosphorylation of OPTN [40, 44] may disrupt the asso-
ciation between OPTN and Rab8, therefore allowing
TBK1-OPTN complexes [44] to leave the Golgi mem-
branes to phosphorylate MAVS or TRIF at the mito-
chondria or endosomes, respectively, for IRF3 activation
[34]. Our observation that p-TBK1S172 accumulates at
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the centrosome at late time points after RLR activation
strongly suggests that the active kinase is released from
the Golgi membranes after its initial trans-autophospho-
rylation at this organelle.
Other adaptors, such as NAP1 or SINTBAD, have
been reported to be involved in TBK1 activation during
innate antiviral immunity [45, 46]. We found that, like
OPTN, both NAP1 and SINTBAD were partially local-
ized at the Golgi apparatus (Additional file 5C), provid-
ing further evidence for a critical role of this organelle in
TBK1 signaling during innate immunity. Further studies
are required to determine whether and how these
adaptors act in concert at the Golgi apparatus to
promote TBK1 activation. Indeed, the weak but never-
theless present, IFN-β response in OPTN-deficient cells
suggests that factors other than OPTN contribute to
TBK1 activity.
Conclusions
At the Golgi apparatus, we propose that, after RNA viral
sensing, OPTN recruits ubiquitinated TBK1 via its UBD,
leading to the trans-autoactivation of this kinase for the
production of type I IFNs after IRF3 phosphorylation
(Additional file 8). Our recent report that the Golgi-
anchored E3 ubiquitin ligase RNF121 is a new player in
the signaling leading to NF-κB activation [47] suggests
that the Golgi apparatus, in addition to its other known
roles, acts as a hub for the formation and/or maturation
of signalosomes, leading to activation of the IRF3 and
NF-κB signaling pathways. It remains to be determined
whether other signaling pathways are relayed by the
Golgi apparatus.
Methods
Cell culture and reagents
HEK293T and HeLa cells were obtained from ATCC.
MEFs and HEK293T cells stably expressing TLR3 were ob-
tained from Invivogen (San Diego, CA, USA). STING–/–,
MAVS–/–, and TBK1 –/– MEFs were kindly provided by
Dr. Glen Barber (Department of Cell Biology and Sylvester
Comprehensive Cancer Center, University of Miami School
of Medicine, Miami, USA), Dr. Jurg Tschopp (Department
of Biochemistry, University of Lausanne, Epalinges,
Switzerland), and Dr. Katherine Fitzgerald (Division of
Infectious Diseases, University of Massachusetts Medical
School, Worcester, USA), respectively. Primary MEFs
isolated from WT or OPTN470T mice were donated
by Dr. Ivana Munitic. All cells were cultured in standard
conditions. Bone marrow cells from WT or OPTN470T
mice were allowed to differentiate in complete DMEM
supplemented with 20 % M-CSF-conditioned medium for
6–7 days.
The TLR3 agonist Poly(I:C) was obtained from Invivogen.
The Sendai virus H4 strain and the vesicular stomatitis
virus mutant strain used to infect cells (multiplicity of
infection = 5) and to stimulate the RLRs were provided by
Dr. Dominique Garcin. Complexes between low or high
molecular weight poly(I:C) and the transfection reagent
Lyovec (Invivogen) were also used to activate RLRs.
Subcellular fractionation
For subcellular organelle fractionation, cells were mechan-
ically disrupted with a 27G1/2 syringe (BD Biosciences,
East Rutherford, NJ, USA) in H60 buffer (20 mM HEPES
pH 7.9, 1.5 mM MgCl2, 60 mM KCl) supplemented with
protease inhibitor cocktail (Thermo Scientific, Illkirch,
France). Samples were centrifuged at 1000 × g to remove
the nuclei and unbroken cells. The supernatant (S1) was
centrifuged at 5000 × g for 5 minutes, to precipitate heavy
organelles (P5). The supernatant (S5) was further centri-
fuged at 10,000 × g for 10 minutes to generate S10 and
P10. S10 was centrifuged at 25,000 × g for 20 minutes to
obtain the cytosolic fraction (S25) and P25. Each pellet
was resuspended in lysis buffer and analyzed by immuno-
blotting. Discontinuous Optiprep gradients were used to
separate the fractions, as previously described [18]. Isola-
tion of Golgi membranes was performed using a Golgi
isolation kit (Sigma Aldrich, St. Louis, MO, USA) accord-
ing to the manufacturer’s instructions.
In vitro IRF3 phosphorylation assays
Cells were disrupted in hypotonic buffer (10 mM Tris/
HCl pH 7.5, 10 mM KCl, 0.5 mM EGTA, 1.5 mM
MgCl2, plus protease inhibitor cocktail); 5 to 15 μg of P5
or P25 in resuspension buffer (20 mM HEPES-KOH
pH 7.4, 10 % glycerol, 0.5 mM EGTA, and protease in-
hibitor cocktail) were mixed with 1 μg of recombinant
GST-IRF3 (Abnova, Taipei City, Taiwan) and reaction
buffer (20 mM HEPES-KOH pH 7.0, 2 mM ATP, 5 mM
MgCl2 and protease inhibitor cocktail) at 30 °C. The
mixture was then cleared by centrifugation and the
supernatant was used for immunoblotting.
Immunofluorescence
Cells were grown on coverslips. They were fixed by incuba-
tion in 4 % paraformaldehyde in phosphate buffered saline
(PBS) for 10 minutes, and then permeabilized by incuba-
tion with 0.15 % Triton X-100 in PBS for 15 minutes. Non-
specific binding sites were blocked by incubating cells in a
solution of 2 % BSA in PBS for 1 hour. The cells were then
incubated for 1 hour at room temperature or overnight at
4 °C with the primary antibodies. They were washed three
times, for five minutes each, in PBS and were then incu-
bated for 1 hour with the specific Alexa Fluor-conjugated
secondary antibodies (Invitrogen, Life Technologies, Grand
Island, NY, USA). Nuclei were stained with DAPI (Sigma)
and cells were again washed three times with PBS. Images
were acquired with a Leica SP5 confocal microscope (Leica
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Microsystems, Wetzlar, Germany) equipped with a 63× oil
immersion fluorescence objective.
DNA transfection and plasmids
HEK293T cells were transfected using Fugene 6 (Promega,
Madison, WI, USA), according to the manufacturer’s
instructions. pcDNA-Myc-TBK1K38M and pcDNA-Myc-
TBK1K30R/K401R were obtained by PCR-directed mu-
tagenesis from pcDNAMyc-TBK1. pLEX-TBK1, pLEX-
TBK1K38M, and pLEX-TBK1K30R/K401R were kindly provided
by Dr. Michael Eck (Department of Cancer Biology, Dana-
Farber Cancer Institute, Boston, USA). Finally, plasmids
encoding NS3-GFP and OPTN-Flag were kindly donated
by Dr. Damien Vitour and Dr. Ivana Munitic, respectively.
Protein extraction, immunoprecipitation and
immunoblots
Cells were lysed in lysis buffer (50 mM Tris-HCl pH 7.4,
150 mM NaCl, 1 % Triton X-100, 2 mM EDTA, 2 mM
sodium pyrophosphate, 25 mM β-glycerophosphate,
1 mM sodium orthovanadate) supplemented with prote-
ase inhibitor cocktail (Thermo Scientific), and the debris
were removed by centrifugation at 10,000 × g and 4 °C.
Protein concentration was determined with a micro
BCA kit (Thermo Scientific). For immunoprecipitation,
the samples were precleared with protein-G-Sepharose
beads (Roche) for 30 minutes before immunoprecipita-
tion with 2.5 μg antibodies and additional protein-G-
Sepharose beads at 4 °C for 2 hours. Samples were then
boiled in SDS sample buffer (Novex, San Diego, CA, USA)
containing 10 % β-mercaptoethanol (Sigma Aldrich) and
resolved by SDS-polyacrylamide gel electrophoresis. The
cells were lysed and their ubiquitin conjugate content was
analyzed at room temperature in denaturing conditions
(8 M urea, 0.1 M NaH2PO4, 10 mM Tris-HCl pH 8, 1 %
Triton X-100, 1 % NP-40, 20 mM imidazole). Immunoblot
analysis was performed with specific antibodies and the
antigen–antibody complexes were visualized by che-
miluminescence (Immobilon Western, Merck Millipore,
Billerica, MA, USA).
Antibodies
The primary antibodies used for immunoblotting were
rabbit monoclonal anti-TBK1 (Abcam, Cambridge, UK,
Abcam Cat# ab40676 RRID:AB_776632, 1:5000 dilution),
rabbit monoclonal anti-phosphorylated TBK1 (phospho
S172) (Abcam Cat# ab109272 RRID:AB_10862438, 1:2000),
rabbit monoclonal anti-phosphorylated TBK1 (phospho
S172) (Cell Signaling Technology, Danvers, MA, USA, Cell
Signaling Technology Cat# 5483P RRID:AB_10693472,
1:2000), rabbit monoclonal anti-IRF3 (Cell Signaling
Technology Cat# 4302S RRID:AB_1904036, 1:5000), rab-
bit monoclonal anti-phosphorylated IRF3 (phospho S386)
(Abcam Cat# ab76493 RRID:AB_1523836, 1:5000), rabbit
monoclonal anti-phosphorylated IRF3 (phospho S396)
(Cell Signaling Technology Cat# 4947S RRID:AB_823547,
1:2000), mouse monoclonal anti-MAVS (Enzo Life
Sciences, Farmingdale, NY, USA, Enzo Life Sciences Cat#
ALX-804-847 RRID:AB_10539976, 1:2000), rabbit poly-
clonal anti-TRAF3 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA, Santa Cruz Biotechnology Cat# sc-1828
RRID:AB_2209427, 1:1000), rabbit polyclonal anti-HA
(Sigma-Aldrich Cat# H6908 RRID:AB_260070, 1:2000),
rabbit polyclonal anti-TRIF (Cell Signaling Technology
Cat# 4596S RRID:AB_2256555, 1:2000), rabbit polyclonal
anti-GAPDH (Sigma-Aldrich Cat# G9545 RRID:AB_
796208, 1:20000), rabbit polyclonal anti-KTN (Santa Cruz
Biotechnology Cat# sc-33562 RRID:AB_2133047, 1:10000),
mouse monoclonal anti-LAMP2 (Santa Cruz Biotechnology
Cat# sc-18822 RRID:AB_626858, 1:10000), mouse mono-
clonal anti-EEA1 (BD Biosciences, East Rutherford, NJ,
USA, BD Biosciences Cat# 610456 RRID:AB_397829,
1:10000), rabbit monoclonal anti-Syntaxin6 (Cell Signaling
Technology Cat# 2869S RRID:AB_2196500, 1:5000), rabbit
polyclonal anti-VDAC (Millipore Cat# AB10527 RRID:AB_
10806766, 1:10000), mouse anti-glutathione-S-transferase
(BD Biosciences Cat# 554805 RRID:AB_395536, 1:2000),
mouse monoclonal anti-Lys-63 specific (Millipore
Cat# 05-1313 RRID:AB_1587585, 1:500), mouse mono-
clonal anti-actin (Sigma-Aldrich Cat# A3853 RRID:
AB_262137, 1:10000), rabbit polyclonal anti-optineurin
(Abcam Cat# ab23666 RRID:AB_447598, 1:5000), rabbit
polyclonal anti-optineurin (Cayman Chemical, Ann Arbor,
MI, USA, Cayman Chemical Cat# 100000 RRID:AB_
10078198, 1:4000), mouse monoclonal anti-optineurin
(Santa Cruz Biotechnology Cat# sc-166576 RRID:
AB_2156554, 1:2000), mouse anti-IKKγ (NEMO) (BD
Biosciences Cat# 611306 RRID:AB_398832, 1:2000), rabbit
polyclonal anti-ERK1/2 (Cell Signaling Technology Cat#
9102 RRID:AB_330744, 1:5000), mouse monoclonal
anti-phosphorylated ERK1/2 (Cell Signaling Technology
Cat# 9106 RRID:AB_331768, 1:2000), rabbit polyclonal
anti-IκBα (Cell Signaling Technology Cat# 9242 L
RRID:AB_823540, 1:5000), mouse monoclonal anti-
phosphorylated-IκBα (Cell Signaling Technology Cat#
9246 L RRID:AB_226714, 1:2000), mouse monoclonal anti-
GFP (Roche Molecular Biochemicals, Basel, Switzerland,
Roche Cat# 11814460001 RRID:AB_390913, 1:2000),
mouse monoclonal anti-GM130 (BD Biosciences Cat#
610822 RRID:AB_398141, 1:4000), and mouse monoclo-
nal anti-giantin (Abcam Cat# ab37266 RRID:AB_880195,
1:2000).
The primary antibodies used for immunofluorescence
were rabbit monoclonal anti-phosphorylated TBK1 (phos-
pho S172) (Abcam Cat# ab109272 RRID:AB_10862438,
1:500 dilution), rabbit monoclonal anti-phosphorylated
TBK1 (phospho S172) (Cell Signaling Technology Cat#
5483P RRID:AB_10693472, 1:250), mouse monoclonal
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anti-IKKε/TBK1 (Cayman Chemical Cat# 13929 RRID:
AB_10679144, 1:500), rabbit monoclonal anti-TBK1
(Abcam Cat# ab40676 RRID:AB_776632, 1:500), rabbit
monoclonal anti-IRF3 (Cell Signaling Technology Cat#
4302S RRID:AB_1904036, 1:500), rabbit polyclonal anti-
IRF3 (Santa Cruz Biotechnology Cat# sc-9082 RRID:
AB_2264929, 1:500), mouse monoclonal anti-GM130
(BD Biosciences Cat# 610822 RRID:AB_398141, 1:1000),
mouse monoclonal anti-cytochrome c (BD Biosciences
Cat# 556432 RRID:AB_396416, 1:1000), mouse mono-
clonal anti-EEA1 (BD Biosciences Cat# 610456 RRID:
AB_397829, 1:500), mouse monoclonal anti-ubiquitin
(Millipore Cat# ST1200-100UG RRID:AB_2043482, 1:200),
mouse monoclonal anti-giantin (Abcam Cat# ab37266
RRID:AB_880195, 1:1000), rabbit polyclonal anti-optineurin
(Abcam Cat# ab23666 RRID:AB_447598, 1:500), rabbit
polyclonal anti-optineurin (Cayman Chemical Cat# 100000
RRID:AB_10078198, 1:500), mouse monoclonal anti-
optineurin (Santa Cruz Biotechnology Cat# sc-166576
RRID:AB_2156554, 1:500) rabbit polyclonal anti-AZI2
(NAP1) (Abcam Cat# ab65242 RRID:AB_1140792, 1:500),
rabbit monoclonal anti-SINTBAD (Cell Signaling Tech-
nology Cat# 8605S RRID:AB_10839270, 1:100), rabbit
polyclonal anti-giantin (Abcam Cat# ab24586 RRID:AB_
448163, 1 :400), mouse monoclonal anti-mouse pericen-
trin (BD Biosciences Cat# 611815 RRID:AB_399295,
1:400) and a rabbit polyclonal anti-pericentrin (Abcam
Cat# ab4448 RRID:AB_304461, 1:400).
The primary antibodies used for immunoprecipitation
were mouse monoclonal anti-optineurin (Santa Cruz
Biotechnology Cat# sc-166576 RRID:AB_2156554), mouse
monoclonal anti-GFP (Roche Cat# 11814460001 RRID:
AB_390913), and rabbit monoclonal anti-TBK1 (Abcam
Cat# ab40676 RRID:AB_776632).
Luciferase assay
HEK293T cells were co-transfected with 50 ng of a con-
struct encoding firefly luciferase under the control of
NF-κB or the IFN-β promoter, and 10 ng of the Renilla
luciferase pRL–TK plasmid (Promega). The transfections
were performed using Fugene 6 (Promega), in accord-
ance with the manufacturer’s instructions. Transfected
cells were collected and luciferase activity was assessed
in the dual-luciferase reporter assay (Promega), on a
Fluorostar Optima machine (BMG Labtech, Ortenberg,
Germany). Each experiment was carried out in triplicate,
with firefly fluorescence units normalized with respect
to Renilla luciferase fluorescence units.
Retroviral transduction of MEFs
Recombinant retroviruses were produced by the transient
transfection of HEK293T cells with the different pLEX-
TBK1 plasmids and plasmids containing a cDNA encod-
ing retroviral packaging gene. Supernatants were collected
48 h after transfection, filtered through a 0.45-nm filter
and concentrated with PEG-IT (Cell Signaling). After in-
fection, cells were selected in puromycin (1 μg/mL) and
further passaged in culture.
Transfection with siRNA
HEK293T cells were transfected by the calcium phosphate
precipitation method, whereas HeLa cells and MEFs were
transfected with the Lipofectamine RNAiMAX (Invitrogen,
Life Technologies), according to the manufacturer’s
instructions. siRNAs were used at a final concentration of
20 nM. Control non-specific siRNAs and the specific
siRNAs were purchased from Sigma-Aldrich. The siRNAs
used were: OPTN 1 (5′ GCUUCAAGAGGCACACAC
AdTdT 3′), OPTN 2 (GUUUGAGAUGCAAAGCAAA
dTdT), mNEMO (GCGAGUUCAACAAGCUGAAdTdT),
OPTN A (GAGUCAUGAGAAUGAGAAAdTdT), OPTN
B (CCAUGAAAGGGAGAUUUGAdTdT), OPTN C (CC
AAAGAAAGAGUUUCAGAdTdT), OPTN D (GAAAG
CAUGCUAUCAGAAAdTdT), OPTN E (CCAAGAAUU
ACUUCGAACAdTdT), and hNEMO (GAGUCGUUGG
AGGCUGCCACUAAGdTdT).
CRISPR/Cas9
OPTN knockout was achieved in HeLa cells with
CRISPR/Cas9 technology, by optineurin double nickase
plasmid transfection (Santa Cruz) and puromycin selec-
tion, according to the manufacturer’s protocol.
Real-time quantitative PCR
RNA was extracted from cells in RLT lysis buffer and
purified with the QIAGEN RNeasy Mini kit, according
to the manufacturer’s protocol. RNA quality was
checked by measuring the ratio of optical densities at
260 and 280 nm. Total RNA (1 μg) was used for cDNA
synthesis with a Revert Aid H minus First Strand DNA
Synthesis kit (Fermentas, Villebon-sur-Yvette, France).
cDNA was then amplified by PCR with a LightCycler
480 (Roche Diagnostics, Basel, Switzerland), using SYBR
Green (Fast Start DNA Master SYBR- Green I; Roche
Applied Science, Roche Diagnostics). Specific primers
were used for IL-6, IFNB1, or GAPDH (as the house-
keeping gene), under the following conditions: 95 °C for
15 minutes, 40 cycles of 94 °C for 15 s, and at 55 °C for
30 s, then 72 °C for 30 s. Specific primers were designed
with the Universal Probe Library System (Roche Applied
Science). The sequences of the primers used were as
follows: hIL-6 (Forward: GAAAGTGGCTATGCAG
TTTGAA, reverse: GAGGTAAGCCTACACTTTCCA
AGA), hIFNB1 (CGACACTGTTCGTGTTGTCA, GAA
GCACAACAGGAGAGCAA), hGAPDH (AGCCACA
TC GCTCAGACAC, AATACGACCAAATCCGTTGA
CT), mIL-6 (GCTACCAAACTGGATATAATCAGGA,
CCAGGTAGCTATGGTACTCCAGAA), mIFNB1 (CAC
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AGCCCTCTCCATCAACTA, CATTTCCGAATGTTCGT
CCT), and mGAPDH (AGCTTGTCATCAACGGGAAG,
TTTGAT GTTAGTGGGGTCTCG). Results are expressed
as 2–ΔCp, where Cp is the cycle threshold number. Dis-
sociation curves were analyzed after each run, for each
amplicon, to assess the specificity of quantification with
SYBR Green.
Enzyme-linked immunosorbent assay (ELISA)
The concentrations of IFN-β and IL-6 released into the
cell culture medium were determined by ELISA, with
the Verikine IFN-β kit (PBL Assay Science, Piscataway,
NJ, USA) and the Quantikine IL-6 kit (R&D Systems,
Minneapolis, MN, USA) for human or mouse cells, ac-
cording to the manufacturer’s protocol.
Statistical analysis
We carried out t tests with Tukey’s post hoc analysis to
assess the statistical significance of differences (Prism
GraphPad Software), and the P values obtained are indi-
cated in the figure legends. Differences were considered
to be significant if P < 0.05. ****P < 0.0001, ***P < 0.001,
**0.001 < P < 0.01, *0.01 < P < 0.05. ns, not significant.
The data shown in each histogram are the means ± SD
from three independent experiments.
Additional files
Additional file 1: p-TBK1S172 localizes to the Golgi apparatus then
migrates to the centrosome after RLR activation. (A) Scheme of the
subcellular fractionation procedure for obtaining the various membrane
fractions in Figs. 1a, 2a, and Additional file 2A. (B) MEFs were either left
unstimulated (control) or infected with Sendai virus (SeV) for 6 h (+ SeV).
p-TBK1S172 staining was then analyzed by immunofluorescence. The Golgi
apparatus was identified by labeling with an antibody raised against giantin.
Scale bars, 10 μm. On the right, enlargement of the framed zone in the
overlay. (C) Isolated Golgi membranes from uninfected or SeV-infected MEFs
were analyzed by immunoblotting with antibodies against the indicated
proteins. ° Corresponds to the p-TBK1 detection from a previous immunoblot.
(D) MEFs were either left unstimulated (control) or infected with SeV for 6 or
9 h (+ SeV). p-TBK1S172 staining was then analyzed by immunofluorescence.
The Golgi apparatus was identified by labeling with an antibody raised
against GM130. Scale bars, 10 μm. On the right, enlargement of the framed
zone in the overlay. (E) MEFs were either left unstimulated (control) or
infected with SeV for 9 h (+ SeV). p-TBK1S172 staining was then analyzed by
immunofluorescence. The centrosomes were stained with an antibody raised
against pericentrin. Scale bars, 10 μm. On the right, enlargement of the
framed zone in the overlay. (PDF 759 kb)
Additional file 2: The active form of TBK1 localizes to the Golgi apparatus
after RLR stimulation. (A) HeLa cells were either left unstimulated or infected
with Sendai virus (SeV) for 6 or 8 h. Cells were then fractionated as described
in Additional file 1A, and samples were analyzed by immunoblotting with
antibodies against the indicated proteins. EEA1, kinectin, LAMP2, GAPDH,
syntaxin-6, and VDAC served as loading and purity controls for endosomes,
the endoplasmic reticulum, lysosomes, the cytosol, the Golgi apparatus, and
mitochondria, respectively. (Ub)n, polyubiquitin. * Indicates non-specific
bands. (B–E) HeLa cells were either left unstimulated (control) or infected
with SeV for 6 h (+ SeV). The indicated proteins were then analyzed by
immunofluorescence staining. The Golgi apparatus was labeled with an
antibody against GM130, whereas the mitochondria were identified by
immunostaining for cytochrome c. Scale bars, 10 μm. On the right,
enlargement of the framed zone in the overlay. (F) HeLa cells were either
left unstimulated or infected with SeV for 6 or 8 h. Cell lysates (Lys.) were
then subjected to immunoprecipitation (IP) with an antibody against TBK1.
Samples were then analyzed by immunoblotting with antibodies against
the indicated proteins. * Indicates non-specific bands. (PDF 2378 kb)
Additional file 3: Transfection of MEFs with poly(I:C) triggers TBK1
accumulation at the centrosome at late time points. (A) MEFs were either
left untreated (MOCK) or transfected with LMW poly(I:C) (5 μg/mL) for 4 h
(trPoly(I:C)). TBK1 staining was then analyzed by immunofluorescence.
The Golgi apparatus was labeled with an antibody against GM130,
whereas TBK1 was detected with a rabbit monoclonal antibody. Scale
bars, 10 μm. (B–E) MEFs were either left untreated (MOCK) or transfected
with HMW poly(I:C) (5 μg/mL) for 4 h (trPoly(I:C)). The indicated proteins
were analyzed by immunofluorescence staining with specific antibodies.
The Golgi apparatus was labeled with an antibody against GM130,
whereas centrosomes were labeled with an antibody against pericentrin.
Scale bars, 10 μm. On the right, enlargement of the framed zone in the
overlay. (PDF 1624 kb)
Additional file 4: The p-TBK1S172 in aggregates is ubiquitinated. MEFs
were either left untreated (MOCK) or transfected with HMW poly(I:C)
(5 μg/mL) for 4 h (trPoly(I:C)). The indicated proteins were analyzed by
immunofluorescence staining with specific antibodies. Scale bars, 10 μm.
(PDF 338 kb)
Additional file 5: OPTN, NAP1 and SINTBAD are present at the Golgi
apparatus where OPTN is in complex with active TBK1 after RLR activation.
(A, C) The indicated proteins were analyzed by immunofluorescence with
specific antibodies in HeLa cells. Anti-OPTN (a), rabbit polyclonal anti-OPTN
from Cayman Corp; anti-OPTN (b), rabbit polyclonal anti-OPTN from Abcam;
anti-OPTN (c), mouse monoclonal anti-OPTN from Santa Cruz. The Golgi
apparatus was stained with a mouse monoclonal anti-GM130 antibody or
with a rabbit polyclonal anti-giantin antibody. Scale bars, 10 μm. (B) HEK293T
cells were either left unstimulated or infected with Sendai virus (SeV) for 6 and
8 h. Golgi-enriched fractions were then subjected to immunoprecipitation
(IP) with an antibody against OPTN. Samples were then analyzed by
immunoblotting with antibodies against the indicated proteins. * Indicates
non-specific bands. (PDF 1007 kb)
Additional file 6: OPTN silencing impairs IRF3 signaling after RLR or
TLR3 activation. (A) HEK293T cells were transfected with a control
nonspecific siRNA (NS) or with five individual OPTNspecific siRNAs
(OPTN A, B, C, D and E) or a NEMO-specific siRNA. The cells were then
transfected, 48 h later, with an IFNβ promoter reporter or with a NF-κB
reporter and the Renilla luciferase gene as an internal control. Then, 24 h
after transfection, cells were either left unstimulated (Unstim) or infected
with Sendai virus (+SeV) for 7 h. Luciferase assays were performed and
the results were normalized against Renilla luciferase activity. The data
shown are means ± SD from three independent experiments (analysis of
variance and comparison with NS siRNA-transfected cells in Student’s
t-test). RLU, relative luminescence units. ns, not significant. (B) HEK293T
cells were transfected with a control nonspecific siRNA (NS) or with two
individual OPTN-specific siRNAs (OPTN A and OPTN B) or a NEMO-
specific siRNA. Then, 72 h later, cells were either left unstimulated or
infected with Sendai virus (SeV) for 6 or 8 h. Cell lysates were analyzed
by immunoblotting with antibodies against the indicated proteins.
* indicates nonspecific bands. (C) As in (B) but with HeLa cells. (D)
HEK293T cells were transfected with a control nonspecific siRNA (NS) or
with two individual OPTN-specific siRNAs (OPTN A and OPTN B) or a
NEMO-specific siRNA. Cells were either left unstimulated (Unstim) or
infected with VSV (+VSV) for 7 h. Luciferase assays were performed and
the results were normalized against Renilla luciferase activity. (E) As in (B)
but HEK293T cells were infected with VSV. (F) HEK293T-TLR3 cells were
transfected as in (A). Cells were either left unstimulated (Unstim) or
stimulated with poly(I:C) (10 μg/ml) for 7 h. Luciferase assays were then
performed. (PDF 703 kb)
Additional file 7: OPTN deficiency does not affect TBK1 ubiquitination.
WT or OPTN knockout HeLa cells were either left unstimulated or infected
with Sendai virus (SeV) for 6 or 8 h. Cell lysates (Lys.) were subjected to
immunoprecipitation (IP) with an antibody against TBK1. Samples were then
analyzed by immunoblotting with antibodies against the indicated proteins.
° Corresponds to OPTN detection from a previous immunoblot. (PDF 392 kb)
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Additional file 8: Working model. After infection, viral RNAs are sensed
by RIG-I in the cytosol or TLR3 in the endosomes. The corresponding
adaptors, MAVS and TRIF, trigger the formation of specific signalosomes
leading to the ubiquitination of TBK1. At the Golgi apparatus, OPTN
recruits ubiquitinated TBK1 via its UBD, leading to the trans-autoactivation
of this kinase. Activated TBK1 then phosphorylates IRF3, leading to the
production of type I IFNs. (PDF 912 kb)
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